These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643 [TBL] [Abstract][Full Text] [Related]
24. Antigen immunohistochemistry of renal cell adenomas in autopsy cases: relevance to histogenesis. Hiasa Y; Kitamura M; Nakaoka S; Ohshima M; Konishi N; Kitahori Y; Hirao K; Fukushima Y; Tho Y; Hayashi I Oncology; 1995; 52(2):97-105. PubMed ID: 7531836 [TBL] [Abstract][Full Text] [Related]
25. Expression of segment-specific antigens in the human nephron and in renal epithelial tumors. Holm-Nielsen P; Pallesen G APMIS Suppl; 1988; 4():48-55. PubMed ID: 2465011 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical studies of human renal cell carcinomas for ABO(H) blood group antigens, T antigen-like substance and carcinoembryonic antigen. Ghazizadeh M; Kagawa S; Kurokawa K J Urol; 1985 May; 133(5):762-6. PubMed ID: 3886935 [TBL] [Abstract][Full Text] [Related]
28. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma. Leroy X; Moukassa D; Copin MC; Saint F; Mazeman E; Gosselin B Eur Urol; 2000 Apr; 37(4):484-7. PubMed ID: 10765081 [TBL] [Abstract][Full Text] [Related]
29. Characteristics of MHC antigen expression and tumor-infiltrating mononuclear cells in renal cell adenomas and carcinomas. Ohmori T; Okada K; Arita N; Watanabe Y; Miyazaki T; Tabei R Histol Histopathol; 1995 Oct; 10(4):789-94. PubMed ID: 8573998 [TBL] [Abstract][Full Text] [Related]
30. Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma. Mathers ME; Pollock AM; Marsh C; O'Donnell M Histopathology; 2002 Jun; 40(6):563-7. PubMed ID: 12047768 [TBL] [Abstract][Full Text] [Related]
31. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Pan CC; Chen PC; Ho DM Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648 [TBL] [Abstract][Full Text] [Related]
32. Immunopathology of adrenal and renal cortical tumors. Coordinated change in antigen expression is associated with neoplastic conversion in the adrenal cortex. Cote RJ; Cordon-Cardo C; Reuter VE; Rosen PP Am J Pathol; 1990 May; 136(5):1077-84. PubMed ID: 1693469 [TBL] [Abstract][Full Text] [Related]
33. Pathology of preneoplastic and neoplastic renal tubular lesions induced in F-344 rats by sodium barbital, a nongenotoxic renal carcinogen and nephrotoxin. Kurata Y; Diwan BA; Uno H; Rice JM; Ward JM Toxicol Pathol; 1993; 21(1):35-45. PubMed ID: 8378705 [TBL] [Abstract][Full Text] [Related]
34. [Classification, histogenesis, and prognosis of renal cell carcinoma and renal oncocytoma]. Störkel S; Jacobi GH Verh Dtsch Ges Pathol; 1989; 73():321-38. PubMed ID: 2482618 [TBL] [Abstract][Full Text] [Related]
35. Expression of MUC1, Thomsen-Friedenreich-related antigens, and cytokeratin 19 in human renal cell carcinomas and tubular clear cell lesions. Cao Y; Karsten U; Zerban H; Bannasch P Virchows Arch; 2000 Feb; 436(2):119-26. PubMed ID: 10755601 [TBL] [Abstract][Full Text] [Related]
36. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma. Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178 [TBL] [Abstract][Full Text] [Related]
37. Renal oncocytoma: diagnostic utility of cytokeratin-containing globular filamentous bodies. Bonsib SM; Bromley C; Lager DJ Mod Pathol; 1991 Jan; 4(1):16-23. PubMed ID: 1708500 [TBL] [Abstract][Full Text] [Related]